Alector (ALEC) Accumulated Expenses (2018 - 2026)
Alector (ALEC) posted quarterly Accumulated Expenses of $10.9 million for Q1 2026, down 36.89% year-over-year from $17.3 million in Q1 2025, and down 43.36% quarter-over-quarter from $19.3 million in Q4 2025.
Alector (ALEC) Accumulated Expenses (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Accumulated Expenses for 9 consecutive years, with $10.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Accumulated Expenses fell 36.89% year-over-year to $10.9 million; the TTM figure through Mar 2026 stood at $10.9 million (down 36.89% YoY), while the FY2025 annual figure was $19.3 million, down 33.2% from the prior year.
- Accumulated Expenses slipped to $10.9 million in Q1 2026 per ALEC's latest filing, from $19.3 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $30.4 million in Q3 2023 and bottomed at $10.9 million in Q1 2026.
- Historically, Accumulated Expenses has averaged $21.1 million across 5 years, with a median of $20.0 million in 2022.
- Annual changes were most pronounced in 2023 — Accumulated Expenses soared 138.11% — and 2025, when it tumbled 38.41%.
- Alector's Accumulated Expenses stood at $12.8 million in 2022, then jumped by 138.11% to $30.4 million in 2023, then retreated by 4.9% to $28.9 million in 2024, then slumped by 33.2% to $19.3 million in 2025, then sank by 43.36% to $10.9 million in 2026.
- Business Quant data shows ALEC's Accumulated Expenses at $10.9 million in Q1 2026, $19.3 million in Q4 2025, and $18.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.04 Mn |
| Mar 31, 2026 | 10.93 Mn |
| Dec 31, 2025 | 19.30 Mn |
| Sep 30, 2025 | 18.33 Mn |
| Jun 30, 2025 | 14.22 Mn |
| Mar 31, 2025 | 17.32 Mn |
| Dec 31, 2024 | 28.89 Mn |
| Sep 30, 2024 | 25.70 Mn |
| Jun 30, 2024 | 23.08 Mn |
| Mar 31, 2024 | 19.39 Mn |
| Dec 31, 2023 | 30.38 Mn |
| Sep 30, 2023 | 30.42 Mn |
| Jun 30, 2023 | 22.92 Mn |
| Mar 31, 2023 | 18.58 Mn |
| Dec 31, 2022 | 12.76 Mn |
| Sep 30, 2022 | 23.23 Mn |
| Jun 30, 2022 | 23.71 Mn |
| Mar 31, 2022 | 20.04 Mn |
| Dec 31, 2021 | 11.66 Mn |
| Sep 30, 2021 | 20.59 Mn |